Biosynex S.A.
ALBIO.PA · PAR
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | €0 | €18 | €26 | €79 |
| - Cash | €5 | €5 | €5 | €20 |
| + Debt | €62 | €62 | €63 | €66 |
| Enterprise Value | €57 | €76 | €84 | €124 |
| Revenue | €51 | €48 | €54 | €50 |
| % Growth | 6.3% | -11.5% | 6.7% | – |
| Gross Profit | -€0 | -€9 | -€11 | €26 |
| % Margin | -0.6% | -19.8% | -19.7% | 51% |
| EBITDA | -€1 | -€9 | -€1 | -€10 |
| % Margin | -2% | -19.4% | -2.3% | -20.3% |
| Net Income | -€49 | -€22 | -€21 | -€18 |
| % Margin | -96.2% | -46.9% | -39.1% | -34.9% |
| EPS Diluted | -3.75 | -1.72 | -1.93 | -1.54 |
| % Growth | -118% | 10.9% | -25.3% | – |
| Operating Cash Flow | – | €1 | -€11 | €0 |
| Capital Expenditures | – | -€3 | -€2 | -€8 |
| Free Cash Flow | – | -€2 | -€13 | -€7 |